Elizabeth Cho, a distinguished Regulatory and Medical Writer at ECF Biosolutions, has contributed to the successful submission of over regulatory dossiers, leading to the IND approval for clinical trials in groundbreaking therapies in oncology, neurodegenerative, infectious and rare diseases. She has exceptional program management skills, steering crossfunctional teams spanning nonclinical, clinical, biostatistics and CMC manufacturing, in resolution meetings keeping to tight timelines.More...